Binding sites with high affinity and spec- Identification of neurotransmitter receptor sites by chemical measurements of direct binding has been reported for nicotinic cholinergic receptors of invertebrate electric organs (1), mammalian neuromuscular junction (2) and central nervous system (3), and for the glycine receptor in the mammalian central nervous system (4). Attempts to study the muscarinic cholinergic receptor biochemically have involved measuring the binding of atropine to the guinea pig intestine (5) and subcellular fractions of rat brain (6). Recently an alkylating agent derived from the muscarinic antagonist benzilylcholine has been employed in the guinea pig intestine (7) and rat brain (8). 3-Quinuclidinyl benzilate (QNB) has been reported to be a potent central muscarinic antagonist (9, 10). Moreover, in the periphery, QNB has been shown to antagonize the acetylcholine-induced contractile response of the guinea pig ileum 50% at 0.01 AoMI (11). Since QNB possesses potency, specificity, and persistence of action, it appears to be a suitable agent for receptor labeling. We now report a simple and sensitive assay for specific muscarinic cholinergic binding in the rat central nervous system using QNB, and describe kinetic properties of the binding, its regional and subcellular localization, and the relative affinity of cholinergic and noncholinergic drugs.
[3H]QNB and tissue concentration and is time-, temperature-, and pH-dependent. The bimolecular rate of association (2.0 X 108 M-1 min-) and dissociation (1. Identification of neurotransmitter receptor sites by chemical measurements of direct binding has been reported for nicotinic cholinergic receptors of invertebrate electric organs (1), mammalian neuromuscular junction (2) and central nervous system (3) , and for the glycine receptor in the mammalian central nervous system (4) . Attempts to study the muscarinic cholinergic receptor biochemically have involved measuring the binding of atropine to the guinea pig intestine (5) and subcellular fractions of rat brain (6) . Recently an alkylating agent derived from the muscarinic antagonist benzilylcholine has been employed in the guinea pig intestine (7) and rat brain (8) . 3-Quinuclidinyl benzilate (QNB) has been reported to be a potent central muscarinic antagonist (9, 10) . Moreover, in the periphery, QNB has been shown to antagonize the acetylcholine-induced contractile response of the guinea pig ileum 50% at 0.01 AoMI (11) . Since QNB possesses potency, specificity, and persistence of action, it appears to be a suitable agent for receptor labeling.
We now report a simple and sensitive assay for specific muscarinic cholinergic binding in the rat central nervous system using QNB, and describe kinetic properties of the binding, its regional and subcellular localization, and the relative affinity of cholinergic and noncholinergic drugs.
MATERIALS AND METHODS
QNB was labeled by catalytic tritium exchange at New England Nuclear Corp., Boston, Mass. Fifty milligrams of QNB dissolved in 0.3 ml of glacial acetic acid were mixed with 25 mg of platinum catalyst and 10 Ci of 3H20. After stirring 18 hr at 800, labile 3H was removed in vacuo with methanol as a solvent and, after filtration from the solvent, the product was dissolved in 10 ml of methanol. In our laboratory, the product was purified by thin-layer chromatography in Silica-Gel F-254 plates, 0. of binding, the specific activity of [3H ]QNB binding is greatest in the crude microsomal fraction, whose specific activity is about 2.5 times that of the crude mitochondrial fraction. Virtually all the binding of the whole homogenate is recovered in the three particulate subcellular fractions. No direct studies have been performed to rule out QNB binding in the soluble supernatant fraction. This pattern of subcellular localization, with the greatest total amount of binding in the crude mitochondrial fraction and the highest specific activity in the microsomal fraction, is similar to results obtained in this laboratory for specific opiate receptor (15) and glycine receptor binding in the rat central nervous system (4) .
Because the crude nuclear fraction displays very little spe- 10-10 10-9 10-11 10-7 10-1 lo-1 10 (Fig. 3) . The fact that half-maximal saturation occurs at similar concentrations of nonradioactive and radiolabeled QNB indicates that [3H ]QNB is biologically equivalent to the nonradioactive drug in terms of receptor binding and confirms the validity of the determined specific activity of [3H ]QNB.
The same maximal displacement of [3H]QNB binding is obtained with oxotremorine as with QNB (Fig. 3) (Fig. 4) (Fig. 4) Muscarinic antagonists have 3 to 5 orders of magnitude more affinity for QNB binding sites than do cholinergic agonists. Similarly, strychnine, a glycine receptor antagonist, has about 1000 times more affinity for the glycine receptor than does glycine itself (4). The affinity of acetylcholine for QNBbinding sites is about the same as that of glycine for the glycine receptor and similar to that of acetylcholine for nicotinic receptor binding sites (19) and norepinephrine (24) and dopamine (25) (1, 19) . The density of apparent muscarinic receptor sites in rat brain is similar to the number of opiate receptors (15) , and to the number of glycine receptors in the rat spinal cord (26) . The number of receptor sites in rat brain we have calculated is the same as that estimated by Hiley et al. (8) for muscarinic sites in rat cerebral cortex by measuring the binding of a radiolabeled homologue of benzilylcholine mustard and similar to that reported for high affinity binding of [3H1jatropine to whole rat brain homogenates (6) .
The binding of [3H]QNB appears closely similar to the binding of a benzilylcholine mustard homologue (8) , and may resemble [3H ]atropine binding to rat brain homogenates (6) .
